Literature DB >> 10936066

Hepatic polyploidy and liver growth control.

S Gupta1.   

Abstract

The onset of cellular polyploidy is recognized in all differentiated mammalian tissues. Polyploidy has been noted frequently in the normal liver, as well as in pathophysiological states of the liver. As insights into the significance of polyploidy accumulate gradually, it is becoming clear that cells belonging to high ploidy classes exhibit advancement toward terminal differentiation and cellular senescence with greater probabilities of apoptosis. Involvement of specific genetic abnormalities, such as impaired DNA repair, may lead to hepatocellular polyploidy. Working models indicate that extensive polyploidy could lead to organ failure, as well as to oncogenesis with activation of precancerous cell clones.

Entities:  

Mesh:

Year:  2000        PMID: 10936066     DOI: 10.1006/scbi.2000.0317

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  67 in total

1.  Conserved balance of hepatocyte nuclear DNA content in mononuclear and binuclear hepatocyte populations during the course of chronic viral hepatitis.

Authors:  Hidenori Toyoda; Takashi Kumada; Olivier Bregerie; Christian Brechot; Chantal Desdouets
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  The insulin/Akt pathway controls a specific cell division program that leads to generation of binucleated tetraploid liver cells in rodents.

Authors:  Séverine Celton-Morizur; Grégory Merlen; Dominique Couton; Germain Margall-Ducos; Chantal Desdouets
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

3.  Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation.

Authors:  Harmeet Malhi; Giridhar R Gorla; Adil N Irani; Pallavi Annamaneni; Sanjeev Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

Review 4.  Polyploidy in liver development, homeostasis and disease.

Authors:  Romain Donne; Maëva Saroul-Aïnama; Pierre Cordier; Séverine Celton-Morizur; Chantal Desdouets
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-02       Impact factor: 46.802

5.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

6.  Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin.

Authors:  Yulia A Nevzorova; Darjus Tschaharganeh; Nikolaus Gassler; Yan Geng; Ralf Weiskirchen; Piotr Sicinski; Christian Trautwein; Christian Liedtke
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

7.  Nuclear fusions contribute to polyploidization of the gigantic nuclei in the chalazal endosperm of Arabidopsis.

Authors:  Célia Baroux; Paul Fransz; Ueli Grossniklaus
Journal:  Planta       Date:  2004-07-10       Impact factor: 4.116

8.  E2F8 is essential for polyploidization in mammalian cells.

Authors:  Shusil K Pandit; Bart Westendorp; Sathidpak Nantasanti; Elsbeth van Liere; Peter C J Tooten; Peter W A Cornelissen; Mathilda J M Toussaint; Wouter H Lamers; Alain de Bruin
Journal:  Nat Cell Biol       Date:  2012-10-14       Impact factor: 28.824

9.  Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model.

Authors:  Brigid Joseph; Sorabh Kapoor; Michael L Schilsky; Sanjeev Gupta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

10.  Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

Authors:  Ágnes Holczbauer; Valentina M Factor; Jesper B Andersen; Jens U Marquardt; David E Kleiner; Chiara Raggi; Mitsuteru Kitade; Daekwan Seo; Hirofumi Akita; Marian E Durkin; Snorri S Thorgeirsson
Journal:  Gastroenterology       Date:  2013-03-19       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.